Data as of Dec 17
| +6.35 / +55.27%|
Volcano Corp. designs, develops, manufactures and commercializes a broad suite of precision guided therapy tools including intravascular ultrasound, and fractional flow reserve products. The company also provides functional management consoles and single-use pressure and flow guide wires, which are used to gauge the impact of arterial plaque on blood flow and pressure. Its products consist of multi-modality consoles which are marketed as stand-alone units or as customized units that can be integrated into a variety of hospital-based interventional surgical suites called catheterization laboratories, or cath labs. The company operates through two segments: Medical and Industrial. The Medical segment includes the manufacture, sale, discovery, development and commercialization of products for the diagnosis of atherosclerosis in the coronary arteries and peripheral vascular system. The Industrial segment includes the discovery, development, manufacture and sale of micro-optical spectrometers and optical channel monitors to telecommunications and other industrial companies. Volcano was founded by Olav B. Bergheim and Samuel Ward Casscells on January 12, 2000 and is headquartered in San Diego, CA.
|R. Scott Huennekens||President, Chief Executive Officer & Director|
|John T. Dahldorf||Chief Financial Officer|
|Michel E. Lussier||President-Clinical & Scientific Affairs|
|Joseph M. Burnett||EVP, GM-Coronary & Systems Business Unit|
|Neil Hattangadi||EVP & General Manager-Peripheral Vascular Business|